Skip to content

A Study to see the number of heart patients using Ayurvedic medicines along with modern medicine and its long term effect

A study to assess the prevalence and effect of concurrent drug therapy mentioned in Indian System of Medicine along with modern drug therapy received in patients with cardio vascular disorders.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/04/013450
Enrollment
400
Registered
2018-04-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- patients attending cardiology OPD IN AIIMS,NEW DELHI

Interventions

None listed

Sponsors

Indian Council of Medical Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult (18-70 years) Male / Female patients visiting the Cardiology OPD. Participant willing to give informed consent and to come for follow up. Patient with coronary artery disease with or without hypertension (stage I & stage II, systolic 140â??180 and diastolic 90â??110). [American Heart Association] Patient with left ventricular dysfunction with NYHA class I& II. Patient taking Ayurvedic drug for any duration to assess the prevalence and taking Ayurvedic drug for the last 6 weeks to assess the effect. Patient should be willing to continue the same drugs as used at the time of enrollment and for the whole follow up period after 6 months.

Exclusion criteria

Exclusion criteria: Patient already recruited for other trial. Inability to comply with the protocol or not willing to give consent. Pregnancy and lactation. Patient suffering only with Hypertension or Hypertension with CVD with (stage III, systolic >180 and diastolic >110) Patient with NYHA class III &IV. Past 3 months h/o or planned for re-vascularisation CABG/ PTCA in next 3 months. Patient who has stopped Ayurvedic drug before follow up. Patient with h/o unstable angina in last three months. Patient taking Ayurvedic drug sine more than 6 weeks to assess the effect. Other major organ dysfunction like renal dysfunction (Blood Urea >50 mg%, S.Creatinine >1.8 mg%) & hepatic dysfunction (AST/ ALT/ ALP/ Total S. Bilirubin > 3 times the upper normal limit ) With other co-morbid conditions like uncontrolled diabetes mellitus, hypertension and malignancy. Any other condition which the investigator thinks may jeopardize the study.

Design outcomes

Primary

MeasureTime frame
To assess the prevalence of the use of Ayurvedic drugs mentioned in Indian System of Medicine along with drugs of Modern medicine. To assess the effect Ayurvedic drugs used along with modern medicine on 6 minute walk test, Quality of Life (QOL) and other routine clinical parameters like blood pressure, Tread Mill Test and Echocardiography Timepoint: for prevelance part at base line and to assess effect at base line and after six months interval.

Secondary

MeasureTime frame
changes in KCCQ SCORE,SAQ SCORE and Change in distance covered in 6Minute Walk Test.Timepoint: base line and 6 months

Countries

India

Contacts

Public ContactPAMILA DUA

AIIMS,New Delhi

skmaulik@gmail.com01126593540

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026